의료 상호운용성 인공지능(AI) : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the healthcare interoperability aI market size reached USD 0.86 billion in 2025 and is projected to reach USD 2.28 billion by 2031, at a CAGR of 18.25% from 2026 to 2031.

This report is Segmented by Component (Software and Others), Application (Data Ingestion and Normalization, and Others), Deployment Mode (Cloud, and Others), End User (Healthcare Providers, and Others), Interoperability Level (Foundational, and Others), and Geography (North America, Europe, Asia-Pacific, and Others). The Market Forecasts are Provided in Terms of Value (USD).

Global Healthcare Interoperability AI Market Trends and Insights

Regulatory Mandates Accelerating FHIR-Based Exchange and API Interoperability

U.S. policy now compels payers to publish and operate four FHIR R4-based APIs by January 1, 2027, covering Patient Access, Provider Access, Payer-to-Payer, and Prior Authorization, with decision timelines set at 7 days standard and 72 hours expedited and with annual public reporting of prior authorization metrics starting in 2026.These rules are built on HL7 FHIR R4 and associated implementation guides that standardize resource models, security, and bulk data access, which reduces integration variability and supports scalable exchange. In Europe, the European Health Data Space sets mandatory interoperability and security obligations by January 2026 for providers and vendors, requires primary-use data exchange of patient summaries and e-prescriptions by March 2029, and phases in imaging and lab data by March 2031 with significant administrative fines for non-compliance. DARWIN EU expanded its evidence-generation capacity through 2025, signaling stronger institutional support for multi-database RWD studies that depend on standardized exchange and curation. U.S. TEFCA governance, alongside Facilitated FHIR, sets neutral exchange conditions that help interoperability move from bilateral connections to network-scale data liquidity. These policies direct investment toward API-first architectures, structured data exchange, and consent-aware workflows that AI systems can use reliably across organizational boundaries.

Payer-Provider Automation Mandates (ePA, Attachments) Scaling AI-Mediated Exchange

Physicians reported high administrative burdens from prior authorization in 2024, including frequent requests and time lost to documentation, which heightened the need for automated evidence retrieval and form completion inside EHR workflows. The HL7 Da Vinci Implementation Guides operationalize ePA through CRD, DTR, and PAS, enabling real-time checks, structured documentation capture, and FHIR-based submission that can be augmented by AI to extract evidence from charts. Federal timelines and public reporting requirements incentivize automation that meets utilization management standards while providing auditable decisions. Early pilots show material cycle-time and approval-rate gains when structured data and NLP are used to pre-populate documented criteria at order time and during appeals. Attachments automation through Da Vinci CDex allows payers to request discrete clinical elements, which scales better than fax-based attachments and supports explainability for clinical reviewers. As regulators and plans scrutinize algorithmic decisions, systems that trace inputs, justifications, and timings will become requirements for sustained ePA performance.

Privacy, Consent, and Cross-Border Data Transfer Constraints

GDPR classifies health data as a special category that requires explicit consent and imposes steep administrative penalties for violations, which increases the cost and complexity of secondary-use pipelines and cross-border flows for AI model development. HIPAA sets U.S. baseline safeguards and breach notification rules, which shape how organizations design encryption, access controls, and risk assessments for PHI in cloud-native environments that run AI workloads. Proposed HIPAA Security Rule updates would formalize stronger requirements on encryption, multifactor authentication, asset inventories, and vulnerability scanning, which can accelerate modernization toward platforms that provide managed security controls. EHDS introduces secure processing environments for secondary-use data, while strict enforcement and reciprocity conditions can limit access for non-EU applicants, which pushes organizations toward in-region compute enclaves. Recorded breach volumes in recent years underscore the need for consent-aware data flows, robust encryption, and audit trails when deploying AI in production pipelines. These governance demands influence vendor selection and architecture patterns across the Healthcare Interoperability AI Market because compliance, consent, and cross-border transfer rules now define technical guardrails for sustained operations.

Other drivers and restraints analyzed in the detailed report include:

1. Cloud-Native Health Data Platforms Embed AI for Unstructured-To-FHIR Conversion
2. RWD/RWE Pipelines Need Automated Normalization and Terminology Mapping
3. Heterogeneous Legacy Systems and Shortages of Skilled Integration Talent

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Software held 48.79% of Healthcare Interoperability AI market share in 2025, while Platforms/Middleware is projected to post the fastest 20.46% CAGR through 2031 as buyers consolidate point connections into orchestrated hubs for reliable real-time data access. This shift reflects the operational need to mediate HL7v2 feeds, bulk exports, and FHIR Subscriptions through consent-aware middleware that enforces a single governance layer across many endpoints. Platform growth is further supported by cloud-native data services that streamline CCDA-to-FHIR conversion, event routing, and validation logs into turnkey workflows, which lowers implementation time and cost for large-scale transformations. Ecosystem vendors publish hundreds of production APIs and notification hooks that third parties consume to build clinical and administrative automation, which increases network effects around high-volume platforms. The Healthcare Interoperability AI Market benefits from platforms that can scale ingestion while ensuring audit trails, access controls, and structured outputs that are ready for analytics and model training.

As endpoint complexity grows, orchestrators reduce maintenance overhead, simplify upgrades to new standards, and create predictable integration patterns that accelerate downstream AI use cases. Platforms combine FHIR-native data stores and managed event infrastructure so developers can subscribe to changes, retrieve context through APIs, and build decision support on top of complete patient and claims histories. High-volume exchange also requires consent-aware enforcement with consistent policy application, which middleware can centralize and document for audits and patient access rights. With regulatory timelines now fixed in major markets, demand has shifted from custom one-off interfaces to scalable platforms that spread operational investment across many use cases. Platform-led approaches also future-proof against new evidence needs and regulatory updates by decoupling data capture from application logic and by standardizing normalized outputs for analytics.

Data Ingestion and Normalization accounted for 46.35% of the Healthcare Interoperability AI market size in 2025, reflecting the foundational need to standardize HL7v2 messages, CCDA files, and other formats into FHIR resources for routine analytics and reporting. Clinical Document Understanding is projected to grow the fastest at a 21.34% CAGR as LLM-enabled extraction turns unstructured notes and reports into structured data that can support ePA, quality measures, and RWD/RWE submissions. Attachment processing and payer workflows are also expanding as AI systems pre-populate evidence fields and track determinations against timelines and audit requirements. These applications rely on source-of-truth references and validation frameworks that confirm variable-level performance and cohort-level replication against established comparators. As event-driven exchange matures, real-time normalization and NLP extraction will feed downstream automation for care coordination and utilization management.

Within the Healthcare Interoperability AI industry, platforms with integrated medical NLP and configurable transformation templates shorten delivery cycles and adapt to local documentation nuances with less overhead. Clinical abstraction tools with read-only EHR connectivity help produce registry-ready outputs with embedded citations, which increases trust and speeds adoption in clinical quality programs. Coding accuracy and revenue improvements follow when human reviewers validate AI-extracted data in refined workflows, which contribute to measurable financial impact for provider organizations. With FDA guidance clarifying credibility expectations, demand is rising for systems that integrate explainability, dataset lineage, and fairness audits into operational pipelines. These capabilities underpin consistent automation across clinical documentation, payer attachments, and regulatory evidence capture.

Geography Analysis

North America accounted for 48.62% share of the Healthcare Interoperability AI market size in 2025, supported by firm CMS timelines for FHIR APIs and by adoption of TEFCA-based exchange models that favor standardized, consent-aware interoperability. Health systems, payers, and vendors are scaling event-driven architectures and automation that rely on AI to extract structured evidence and to power ePA, quality programs, and operations analytics. TEFCA implementation sets shared expectations for nondiscriminatory access, which improves cross-network exchange and expands the platform opportunity for API-first orchestration. Vendor investments in FHIR APIs, notifications, and workflow-enablement accelerate in this environment, which raises the baseline for real-time harmonization and for LLM-based extraction integrated into clinical systems. As a result, the Healthcare Interoperability AI Market in North America is characterized by policy-led adoption and rapid platform improvements that support both administrative and clinical exchange.

Europe is building a comprehensive framework under EHDS that sets deadlines for interoperable primary-use data exchange and a governance model for secondary-use access through secure processing environments, which supports AI development and evidence generation. DARWIN EU expands the supply of regulatory-grade RWD studies and elevates the importance of standardized data flows and common models to enable rapid, multi-country analyses. As EHDS deadlines approach, European providers and vendors must align systems to FHIR profiles and secure exchange requirements, which creates demand for platforms that standardize and automate transformations and events. These changes position the Healthcare Interoperability AI Market in Europe for higher baseline interoperability and broader secondary-use access that can be harnessed for analytics, surveillance, and AI model validation. Policy strength coexists with varied national implementations, which sustains near-term demand for orchestration layers that can align heterogeneous local systems into consistent flows.

Asia-Pacific is projected to be the fastest-growing region at a 22.27% CAGR as national health stacks and FHIR-centered programs expand access, standardize exchange, and embed AI in public health and chronic disease management workflows. Cloud-first deployments in several APAC markets avoid legacy constraints and favor managed services that deliver security, auditability, and rapid AI enablement for streaming data sources. Public-sector initiatives across the region are incorporating standards-based exchange that supports population-level analytics and cross-institutional coordination, which increases the role of event-driven architectures for critical use cases. The Healthcare Interoperability AI Market in APAC therefore benefits from greenfield design, regulatory support for modernization, and growing demand for consent-aware AI deployment that can scale across diverse health systems. As these programs mature, platform providers that combine standardized ingestion, real-time notifications, and strong governance will capture growth opportunities across this region.

1. Amazon Web Services
2. Change Healthcare (Optum)
3. CitiusTech
4. Datavant
5. Edifecs
6. Epic Systems
7. Experian Health
8. GE Healthcare
9. Google Cloud
10. IBM
11. Informatica
12. InterSystems
13. Lyniate (Rhapsody & Corepoint)
14. Microsoft
15. NextGen Healthcare
16. Oracle
17. Particle Health
18. Redox
19. Smile Digital Health
20. Snowflake
21. Verato

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Regulatory Mandates Accelerating FHIR-Based Exchange and API Interoperability
  • 4.2.2 Payer-Provider Automation Mandates (ePA, Attachments) Scaling AI-Mediated Exchange
  • 4.2.3 Cloud-Native Health Data Platforms Embed AI for Unstructured-To-FHIR Conversion
  • 4.2.4 RWD/RWE Pipelines Need Automated Normalization and Terminology Mapping
  • 4.2.5 LLM-Assisted Clinical Document Understanding Reduces Integration Backlog
  • 4.2.6 Event-Driven Streaming (FHIR Subscriptions, IoMT) Enabling Real-Time Harmonization
• 4.3 Market Restraints
  • 4.3.1 Privacy, Consent, and Cross-Border Data Transfer Constraints
  • 4.3.2 Heterogeneous Legacy Systems and Shortages of Skilled Integration Talent
  • 4.3.3 Validation Burden and Explainability Risks for AI-Generated Mappings
  • 4.3.4 Ecosystem Lock-In and Commercial Disincentives to Portability
• 4.4 Value-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Component
  • 5.1.1 Software
  • 5.1.2 Services
  • 5.1.3 Platforms/Middleware
• 5.2 By Application
  • 5.2.1 Data Ingestion and Normalization
  • 5.2.2 Clinical Document Understanding
  • 5.2.3 Patient Matching and Identity Resolution
  • 5.2.4 Prior Authorization and Claims Attachments Automation
  • 5.2.5 Others
• 5.3 By Deployment Mode
  • 5.3.1 Cloud
  • 5.3.2 On-Premises
  • 5.3.3 Hybrid
• 5.4 By End User
  • 5.4.1 Healthcare Providers
  • 5.4.2 Healthcare Payers
  • 5.4.3 Life Sciences / Pharma Companies
  • 5.4.4 Others
• 5.5 By Interoperability Level
  • 5.5.1 Foundational
  • 5.5.2 Structural
  • 5.5.3 Semantic
  • 5.5.4 Organizational
• 5.6 By Geography
  • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
  • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
  • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
  • 5.6.4 Middle East and Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East and Africa
  • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, Recent Developments)
  • 6.3.1 Amazon Web Services
  • 6.3.2 Change Healthcare (Optum)
  • 6.3.3 CitiusTech
  • 6.3.4 Datavant
  • 6.3.5 Edifecs
  • 6.3.6 Epic Systems Corporation
  • 6.3.7 Experian Health
  • 6.3.8 GE HealthCare
  • 6.3.9 Google Cloud
  • 6.3.10 IBM
  • 6.3.11 Informatica
  • 6.3.12 InterSystems
  • 6.3.13 Lyniate (Rhapsody & Corepoint)
  • 6.3.14 Microsoft
  • 6.3.15 NextGen Healthcare
  • 6.3.16 Oracle
  • 6.3.17 Particle Health
  • 6.3.18 Redox
  • 6.3.19 Smile Digital Health
  • 6.3.20 Snowflake
  • 6.3.21 Verato

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment